Stoke Therapeutics Inc buy Chardan Capital
Start price
20.12.24
/
50%
€10.70
Target price
20.12.25
€23.06
Performance (%)
152.34%
End price
21.12.25
€27.00
Summary
This prediction ended on 21.12.25 with a price of €27.00. With a performance of 152.34% the BUY prediction by Chardan_Capital was a big success. Chardan_Capital has a follow-up prediction for Stoke Therapeutics Inc where he still thinks Stoke Therapeutics Inc is a Buy. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Stoke Therapeutics Inc | 4.615% | 4.615% | 166.667% |
| iShares Core DAX® | -0.821% | -2.027% | 9.725% |
| iShares Nasdaq 100 | -1.743% | -5.354% | -0.863% |
| iShares Nikkei 225® | 1.215% | 6.383% | 27.786% |
| iShares S&P 500 | -1.167% | -3.462% | 0.098% |
Comments by Chardan_Capital for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics, Inc. (NASDAQ: STOK) is now covered by analysts at Chardan Capital. They set a "buy" rating and a $24.00 price target on the stock.
Ratings data for STOK provided by MarketBeat
In the thread Trading Stoke Therapeutics Inc
Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten
Current prediction by Chardan_Capital for Stoke Therapeutics Inc
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€8.95
19.02.25
19.02.25
€23.00
19.02.26
19.02.26
203.91%
11.02.26
11.02.26
Stopped prediction by Chardan_Capital for Stoke Therapeutics Inc
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€25.80
05.01.26
05.01.26
€29.93
05.01.27
05.01.27
5.43%
11.02.26
11.02.26
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€13.80
13.08.25
13.08.25
€20.55
13.08.26
13.08.26
97.10%
11.02.26
11.02.26